3p21.3 tumor suppressor cluster: prospects for translational applications.
about
LZTFL1 suppresses gastric cancer cell migration and invasion through regulating nuclear translocation of β-cateninPro-tumorigenic effects of miR-31 loss in mesothelioma.Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell linesLoss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancerTumor-suppressive functions of leucine zipper transcription factor-like 1.Ovine pulmonary adenocarcinoma: a large animal model for human lung cancerPhase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humansTUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug AuranofinHD-PTP is a catalytically inactive tyrosine phosphatase due to a conserved divergence in its phosphatase domain.Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.Localization of an hTERT repressor region on human chromosome 3p21.3 using chromosome engineering.Genomic events associated with progression of pleural malignant mesothelioma.Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.Regulation of tumor suppressor gene FUS1 expression by the untranslated regions of mRNA in human lung cancer cells.A tumor-suppressing function in the epithelial adhesion protein Trask.Frequent loss of the BLID gene in early-onset breast cancer.Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal CancersExogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene.Genome-Wide Association Study of Golden Retrievers Identifies Germ-Line Risk Factors Predisposing to Mast Cell Tumours.Tumor suppressor FUS1 signaling pathway.Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancerDifferential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues.The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers.Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray AnalysisEpigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis.Trask loss enhances tumorigenic growth by liberating integrin signaling and growth factor receptor cross-talk in unanchored cellsCalcium and cancer: targeting Ca2+ transport.Tumor suppressor gene RBM5 delivered by attenuated Salmonella inhibits lung adenocarcinoma through diverse apoptotic signaling pathwaysNovel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancerThe chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer developmentRBM5 reduces small cell lung cancer growth, increases cisplatin sensitivity and regulates key transformation-associated pathways.Haplo-insufficiency: a driving force in cancer.Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells.TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC).Gene Therapy for Lung Cancer.
P2860
Q24300514-27EA64F3-B6E4-4288-B41A-ECE7284264F4Q24607181-6EA736CF-19D8-4C00-BF56-66A607926CDDQ24611593-269261A4-BFDC-4443-9204-0457CF2E103CQ24632794-5A51A493-2BF2-4071-BA07-5DBDFD604024Q27967673-89B3C1FB-CF44-44D0-899F-7F6A75D85EBBQ28088774-DBC183EE-5C96-41AE-B0BA-3100351E7F0CQ28482937-7ACF6BF1-A898-4764-9B66-AF1BE6DE1958Q28595756-15B36758-AA42-4CAE-8BDC-5513197AF3C0Q33425933-E6CC4CCB-3E43-441F-958E-8883CEA77460Q33535501-80DFB527-23F3-4DDC-833B-5B25F872F5E1Q34009738-0B0CB58C-BAEA-490B-B596-10E6EF34FEB8Q34103109-4950B796-4117-4D72-AC3B-F0D8851431B9Q34764447-107363B6-3B25-417A-A9A1-656C5082DC62Q35085626-8A11FA21-08A5-4594-94A6-6A47B515E452Q35250126-7972CF3B-E1C6-4F5C-9CE2-9D0634C50E2DQ35545663-94EB1A2B-F8C9-4ACB-9F61-2FD2F1B986D0Q35593032-6F7038FD-A48C-4A7A-96F2-B22AA03CFF05Q35656213-A0A33250-79EA-46B4-B5A0-31D154D49F5DQ35667390-9862341F-8295-411F-85B8-C893C6F8049DQ35847076-71CC58CA-CF6E-417B-BA98-B38BB9512909Q36018413-B5128375-3733-419D-9347-CE0231BC5570Q36021953-096FA7BC-0ADB-4C0D-B8DA-AC7B8A911202Q36112781-30C722D0-F16D-479A-8903-B2FE9AE5E069Q36128798-56E023D5-E76E-4270-B526-CED343FA5FCEQ36150385-FD1AFF3E-CB05-4874-8509-AF761B29FD4EQ36517724-C6B019EB-EDFB-4A82-91C2-D8A3F9B89A4FQ36531482-2C034391-D1EC-4E98-99C2-DDCE05603850Q36586280-F488D040-89F3-4EA6-90AB-12B058812655Q36856463-3B62841C-2E00-42C4-AB32-77FC997C6B26Q36905752-4D3EAAC0-50B8-4350-A4E8-04F06858AA81Q36906172-A30CE298-5561-4713-B45C-F8A390AEEEBEQ37018751-A747A462-B6F0-4288-8FA5-9855412788A3Q37465032-4020DAE5-5278-4941-800F-390CC3CE808BQ37815124-F8A2CE54-B544-496E-A868-B99596635889Q38828889-86B93634-8BD4-413D-A0FD-596CA5905DD2Q47127243-8A8D4BCA-6231-4240-B3C3-B901CC51D99FQ51601238-BB11467D-EDCD-4E69-9959-D95D13DE76FE
P2860
3p21.3 tumor suppressor cluster: prospects for translational applications.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
3p21.3 tumor suppressor cluster: prospects for translational applications.
@ast
3p21.3 tumor suppressor cluster: prospects for translational applications.
@en
type
label
3p21.3 tumor suppressor cluster: prospects for translational applications.
@ast
3p21.3 tumor suppressor cluster: prospects for translational applications.
@en
prefLabel
3p21.3 tumor suppressor cluster: prospects for translational applications.
@ast
3p21.3 tumor suppressor cluster: prospects for translational applications.
@en
P2093
P2860
P356
P1433
P1476
3p21.3 tumor suppressor cluster: prospects for translational applications.
@en
P2093
P2860
P356
10.1517/14796694.1.1.79
P407
P577
2005-02-01T00:00:00Z